Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. N'-methylamisulpride
2. N'-methyl Amisulpride
3. N81wkw91xf
4. Unii-n81wkw91xf
5. 2227154-23-4
6. 4-(methylamino)-n-(((2rs)-1-ethylpyrrolidin-2-yl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide.
7. Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxy-4-(methylamino)-
8. Refchem:152592
9. Rac-n-methyl Amisulpride
10. Orb2695637
11. Chembl4594422
12. Schembl20189909
13. Schembl29494158
14. Bdbm313180
15. Ex-a11598
16. Lb 102
17. Us10167256, Compound 102
18. 4-methylamino-n-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl))-2-methoxybenzamide
19. N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxy-4-(methylamino)benzamide;
| Molecular Weight | 383.5 g/mol |
|---|---|
| Molecular Formula | C18H29N3O4S |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 8 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 96.1 |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 563 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
21
PharmaCompass offers a list of Lb-102 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Lb-102 manufacturer or Lb-102 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lb-102 manufacturer or Lb-102 supplier.
A LB 102 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LB 102, including repackagers and relabelers. The FDA regulates LB 102 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LB 102 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A LB 102 supplier is an individual or a company that provides LB 102 active pharmaceutical ingredient (API) or LB 102 finished formulations upon request. The LB 102 suppliers may include LB 102 API manufacturers, exporters, distributors and traders.
LB 102 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LB 102 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right LB 102 GMP manufacturer or LB 102 GMP API supplier for your needs.
A LB 102 CoA (Certificate of Analysis) is a formal document that attests to LB 102's compliance with LB 102 specifications and serves as a tool for batch-level quality control.
LB 102 CoA mostly includes findings from lab analyses of a specific batch. For each LB 102 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LB 102 may be tested according to a variety of international standards, such as European Pharmacopoeia (LB 102 EP), LB 102 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LB 102 USP).
